Literature DB >> 9334398

Kappa2 opioid receptors in limbic areas of the human brain are upregulated by cocaine in fatal overdose victims.

J K Staley1, R B Rothman, K C Rice, J Partilla, D C Mash.   

Abstract

Cocaine is thought to be addictive because chronic use leads to molecular adaptations within the mesolimbic dopamine (DA) circuitry that affect motivated behavior and emotion. Although the reinforcing effects of cocaine are mediated primarily by blocking DA reuptake into the presynaptic nerve terminal, reciprocal signaling between DA and endogenous opioids has important implications for cocaine dependence. The present study used the opioid antagonist 6 beta-[125iodo]-3,14-dihydroxy-17-cyclopropylmethyl-4,5 alpha-epoxymorphinan ([125I]IOXY) after pretreatment with the site-directed acylating agents 2-(p-ethoxybenzyl)-1-diethylaminoethyl-5-isothiocyanatobenzimid iazole -HCl (mu-selective) and N-phenyl-N-[1-(2-(4-isothiocyanato)-phenethyl)-4-piperidinyl]-p ropana mide-HCl (delta-selective) to examine the effect of cocaine exposure on the distribution and density of kappa2 receptors in autopsy studies of human cocaine fatalities. The selective labeling of the kappa2 receptor subtype was demonstrated by competition binding studies, which gave a pharmacological signature (IOXY >/= (+)-bremazocine >> U50,488 >/= U69,593) distinct from either the kappa1 or kappa3 receptor subtypes. Visualization of [125I]IOXY labeling revealed that kappa2 receptors localize to mesocortical and subcortical limbic areas, including the cingulate, entorhinal, insular, and orbitofrontal cortices and the nucleus accumbens and amygdala. The number of kappa2 receptors in the nucleus accumbens and other limbic brain regions from cocaine fatalities was increased twofold as compared with age-matched and drug-free control subjects. Cocaine overdose victims, who experienced paranoia and marked agitation before death, also had elevated densities of kappa2 receptors in the amygdala. These findings demonstrate for the first time that kappa2 receptor numbers are upregulated by cocaine exposure. The molecular adaptation of kappa2 receptor numbers may play a role in the motivational incentive associated with episodes of binge cocaine use and in the dysphoria that follows abrupt cocaine withdrawal.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9334398      PMCID: PMC6573759     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  53 in total

1.  Influence of a single injection of cocaine, amphetamine or GBR 12909 on mRNA expression of striatal neuropeptides.

Authors:  Y L Hurd; M Herkenham
Journal:  Brain Res Mol Brain Res       Date:  1992-11

2.  Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway.

Authors:  R Spanagel; A Herz; T S Shippenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

Review 3.  Implications of the multiplicity of opioid receptors for the problem of addiction.

Authors:  A Herz
Journal:  Drug Alcohol Depend       Date:  1990-04       Impact factor: 4.492

4.  Effects of buprenorphine and naltrexone on reinstatement of cocaine-reinforced responding in rats.

Authors:  S D Comer; S T Lac; L K Curtis; M E Carroll
Journal:  J Pharmacol Exp Ther       Date:  1993-12       Impact factor: 4.030

5.  Cocaine alters opiate receptor binding in critical brain reward regions.

Authors:  R P Hammer
Journal:  Synapse       Date:  1989       Impact factor: 2.562

6.  'Binge' cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen.

Authors:  R Spangler; E M Unterwald; M J Kreek
Journal:  Brain Res Mol Brain Res       Date:  1993-09

7.  The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat.

Authors:  C A Heidbreder; S R Goldberg; T S Shippenberg
Journal:  Brain Res       Date:  1993-07-09       Impact factor: 3.252

8.  The role of mu- and kappa-opioid receptors in cocaine-induced conditioned place preference.

Authors:  T Suzuki; Y Shiozaki; Y Masukawa; M Misawa; H Nagase
Journal:  Jpn J Pharmacol       Date:  1992-04

Review 9.  The kappa-opioid receptor: evidence for the different subtypes.

Authors:  M Wollemann; S Benyhe; J Simon
Journal:  Life Sci       Date:  1993       Impact factor: 5.037

10.  Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor.

Authors:  Y X Pan; J Cheng; J Xu; G Rossi; E Jacobson; J Ryan-Moro; A I Brooks; G E Dean; K M Standifer; G W Pasternak
Journal:  Mol Pharmacol       Date:  1995-06       Impact factor: 4.436

View more
  20 in total

1.  kappa-Opioid tolerance and dependence in cultures of dopaminergic midbrain neurons.

Authors:  F C Dalman; K L O'Malley
Journal:  J Neurosci       Date:  1999-07-15       Impact factor: 6.167

Review 2.  Drug abusers who die during arrest or in custody.

Authors:  S B Karch; B G Stephens
Journal:  J R Soc Med       Date:  1999-03       Impact factor: 5.344

3.  Cocaine: history, use, abuse.

Authors:  S B Karch
Journal:  J R Soc Med       Date:  1999-08       Impact factor: 5.344

Review 4.  Functional genomics and psychiatric illness.

Authors:  Wendy Hasenkamp; Scott E Hemby
Journal:  Prog Brain Res       Date:  2002       Impact factor: 2.453

Review 5.  Neuropeptide Y Y2 receptor in health and disease.

Authors:  S L Parker; A Balasubramaniam
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

6.  Functional genomics approaches to a primate model of autistic symptomology.

Authors:  S E Hemby; M M Sanchez; J T Winslow
Journal:  J Autism Dev Disord       Date:  2001-12

Review 7.  The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse.

Authors:  Sunmee Wee; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2010-03-30       Impact factor: 4.530

8.  Acute excited states and sudden death. Death after restraint can be avoided.

Authors:  D Pounder
Journal:  BMJ       Date:  1998-04-11

Review 9.  The opioid receptors as targets for drug abuse medication.

Authors:  Florence Noble; Magalie Lenoir; Nicolas Marie
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

Review 10.  Cocainomics: new insights into the molecular basis of cocaine addiction.

Authors:  Scott E Hemby
Journal:  J Neuroimmune Pharmacol       Date:  2010-03       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.